RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 15 filers reported holding RECRO PHARMA INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,081,000 | +69.7% | 58,993 | +2.7% | 0.10% | +83.6% |
| Q3 2019 | $637,000 | +305.7% | 57,463 | +83.6% | 0.06% | +400.0% |
| Q2 2018 | $157,000 | +72.5% | 31,303 | +207.1% | 0.01% | +57.1% |
| Q4 2015 | $91,000 | -83.8% | 10,194 | -78.2% | 0.01% | -82.5% |
| Q3 2015 | $561,000 | +40.6% | 46,673 | +50.9% | 0.04% | +33.3% |
| Q2 2015 | $399,000 | +200.0% | 30,929 | +110.4% | 0.03% | +233.3% |
| Q1 2015 | $133,000 | – | 14,701 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 3,510,000 | $6,318,000 | 5.40% |
| Cowen Prime Advisors LLC | 4,162,500 | $7,493,000 | 3.15% |
| Athyrium Capital Management, LP | 2,202,420 | $3,964,000 | 1.41% |
| AWM Investment Company, Inc. | 5,081,901 | $9,147,000 | 1.18% |
| Parkman Healthcare Partners LLC | 671,817 | $1,209,000 | 0.35% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 799,841 | $1,440,000 | 0.18% |
| Rubric Capital Management LP | 1,076,587 | $1,938,000 | 0.07% |
| TITLEIST CAPITAL, LLC | 180,093 | $324,000 | 0.06% |
| Clear Harbor Asset Management, LLC | 266,972 | $481,000 | 0.06% |
| Frontier Wealth Management LLC | 64,605 | $2,701,000 | 0.03% |